secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001213900-24-037139
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen amends warrants to $2.00, defers repayment on $550K notes
---------------------------------------------------------------

- Amended and restated 8.2M warrants: cashless conversion delayed, exercise price reset to $2.00/share.
- Entered letter agreements with Meteora and Sandia on $550K notes to defer repayment right until Excess Proceeds exceed $10M.
- Paid $116K cash, issued 416,667 shares, and 550,000 warrants at $2.00 to noteholders.
- Warrants to noteholders have 5-year term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024037139/0001213900-24-037139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024037139/ea0204784-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-037139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer